DocDollars

Acorda Therapeutics, Inc

NY · United States · Reporting entity ID 100000010800

Total reported 2019–2025
$8.04M
#562 of 2,960 reporting companies — 0% of all reported industry payments
$6.82M in general payments across 34,029 records, plus $1.22M in research funding across 74 records.

How it breaks down

General payments $6,819,166
Research funding $1,222,053

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Acorda Therapeutics, Inc reported $8.04M to US doctors and teaching hospitals from 2019 to 2025, ranking #562 of 2,960 reporting companies. 15% of that was research funding and 85% general payments such as consulting, speaking, food and travel. 34,029 general payment records and 74 research records were filed.

Common questions about Acorda Therapeutics, Inc

How much has Acorda Therapeutics, Inc paid US doctors?

Acorda Therapeutics, Inc reported $8,041,220 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $6,819,166 in general payments, $1,222,053 in research funding.

How does Acorda Therapeutics, Inc rank among drug and device companies?

It ranks #562 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Acorda Therapeutics, Inc mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.